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Abstract
The availability of biomarkers that allow the estimation of the intake of specific foods and dietary components, as an alternative or addition
to self-reported dietary questionnaires, could greatly enhance the effectiveness of nutritional research. The aim of the present study was to
assess tartaric acid, one of the major components of red and white wines, as a potential biomarker of wine consumption. A total of twenty-
one healthy men participated in a randomised cross-over feeding trial. They consumed a single dose of 100, 200 or 300 ml wine at dinner.
Before each intervention, the participants followed a 7 d washout period during which they avoided consuming wine or grape-based
products. Morning urine was collected and analysed by liquid chromatography coupled to electrospray ionisation tandem MS. A strong
significant correlation was found between wine intake and urinary tartaric acid (rs ¼ 0·9220; P , 0·001). Using a cut-off value of
8·84mg/mg creatinine, tartaric acid allowed wine consumers to be differentiated from non-wine consumers. The results suggest that urinary
tartaric acid may be a sensitive and specific dietary biomarker of wine consumption.
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Some of the disadvantages associated with self-reported dietary
questionnaires in epidemiological and clinical studies(1,2) can
be overcome by using biomarkers that provide a more objec-
tive assessment of nutrient intake(3–5). In the case of wine, a
biomarker of intake might reflect consumption more accurately
than a questionnaire, as individuals may be reluctant to accu-
rately report customary drinking level due to the social undesir-
ability of excessive alcoholic beverage consumption(6).
Total urinary resveratrol metabolites (TRM) have been
proposed as biomarkers of wine intake in both clinical and
epidemiological studies(7,8), although the high variation in
resveratrol content between red and white wines, as a result
of different oenological practices, and also between grape
varieties(9,10), is an important limitation. In addition, the
varying microbiological metabolism reported for resveratrol(11)
could contribute to a higher variation. Therefore, to obtain
greater insight into the health effects of moderate wine drink-
ing, new reliable biological markers for wine intake are needed.
In this context, tartaric acid might be a promising candidate,
as it accounts for a major fraction of wines, normally within
the range of 1·5–4·0 g/l(12,13). Tartaric acid, the main acid
responsible for wine acidity, is a natural organic acid occurring
in grapes at a high concentration (up to 1 % of whole fresh
grapes), but rare in most other common plants(13,14). This fact
provides high selectivity for tartaric acid when compared with
other wine constituents. Furthermore, tartaric acid is not
degraded during the winemaking process, and hence its levels
remain relatively constant in both red and white wines(13).
Studies on its metabolism in human subjects have suggested
that tartrate excreted in the urine is mainly from dietary sources.
*Corresponding author: R. M. Lamuela-Ravento´s, fax þ34 93 4035931, email lamuela@ub.edu
Abbreviations: LC–ESI-MS/MS, liquid chromatography coupled to electrospray ionisation tandem MS; ROC, receiver-operating characteristic; TRM, total
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Unlike other fruit acids (such as malic and citric acids), which
are digested and converted to energy in the body, tartaric acid
mostly bypasses the small intestine and is fermented by
colonic bacteria, and has been shown to have a beneficial
role in intestinal function(15).
Lord et al.(16) reported a significant increase in urinary
tartaric acid after consumption of grape juice, while Va´zquez-
Fresno et al.(17) observed that its urinary concentrations were
significantly higher in wine consumers than in non-wine
consumers.
Nevertheless, the use of urinary tartaric acid as a biomarker of
wine consumption has not been formally assessed. Therefore,
we evaluated the usefulness of tartaric acid as a wine biomarker
in a randomised, controlled, cross-over clinical trial conducted
in healthy male volunteers.
Materials and methods
Reagents and standards
L-(þ)-Tartaric acid and creatinine were purchased from Sigma.
The labelled internal standard DL-(^)-tartaric-2,3-d2 acid was
obtained from C/D/N Isotopes. Formic acid (approximately
98 %), picric acid (98 %, moistened with approximately 33 %
water) and sodium hydroxide ($98 %) were purchased from
Panreac. Solvents were HPLC grade and all other chemicals
were analytical reagent grade. Ultrapure water was obtained
from a Milli-Q Gradient water purification system (Millipore).
Stock solutions of tartaric acid were prepared in water.
Different working standard solutions were made by appropri-
ate dilution in 0·5 % formic acid in water and then stored in
amber glass vials at 2208C.
Wine samples
A commercial red wine from the Spanish Protected Designation
of Origin ‘Rioja’ was used over the course of the present study. It
was elaborated with grapes of Vitis vinifera L. and consisted of a
blend of Tempranillo (85 %) and Graciano and Garnacha Tinta
(15 %) varieties from the 2009 vintage. To ensure its homo-
geneity, the wine belonged to the same batch and was bottled
on the same day. The wine had a pH value of 3·7 and 13·0 %
alcohol by volume. The content of tartaric acid was determined
by liquid chromatography coupled to electrospray ionisation
tandem MS (LC–ESI-MS/MS) as described previously(18).
Tartaric acid level in this wine was 1737 (SD 17) mg/l (n 3).
Subjects and study design
A total of twenty-one Caucasian healthy men, with a mean age
of 30·7 (SD 5·9) years (median 30·0 years; range 21–50 years)
and a mean BMI of 24·7 (SD 2·7) kg/m2 (median 24·2 kg/m2;
range 19·8–32·9 kg/m2), participated in a randomised cross-
over feeding trial.
The subjects were non-smokers; had no history of cardio-
vascular, hepatic or renal disease; had no acute or chronic
infection, inflammatory disease or endocrine disorders; had
no anti-inflammatory, corticosteroid, hormonal or antibiotic
drug treatment during the previous 3 months; had no history
of alcohol abuse or drug dependence; and had not adhered
to any special diets at least 4 weeks before the commence-
ment of the study. Only male subjects were recruited, in
order to reduce the menstrual cycle phase-related variability
in women, putatively affecting the absorption, metabolism
and excretion processes.
The present study was conducted according to the guidelines
laid down in the Declaration of Helsinki, and all procedures
involving human subjects were approved by the Ethics
Committee of Clinical Investigation of the University of
Barcelona (Spain) (reference no. IRB0003099). Written
informed consent was obtained from all subjects. The study
protocol followed the recommendations made in the
CONSORT (Consolidated Standards of Reporting Trials)
guidelines(19). The present trial was registered at controlled-
trials.com as ISRCTN63399546.
The interventions consisted of intake at dinner, in a random
order, of 100, 200 and 300 ml red wine, corresponding to
10·3, 20·5 and 30·8 g ethanol, respectively. The participants
were randomly assigned following simple randomisation
procedures (computerised random numbers) to one of three
treatment groups. Before each intervention, the participants
followed a 7 d washout period during which they were
requested to avoid consuming wine or grape-based products.
First morning urine samples were collected the day before
the first intervention and in the morning following each inter-
vention (Fig. 1). All samples were collected in 100 ml random
coded sterile specimen containers, and immediately stored at
48C. Upon receipt of each sample, four aliquots of 1·0 ml
were transferred to separate 1·5 ml capped Eppendorf tubes
and stored at 2808C until the analyses, which were performed
with no knowledge of the clinical data.
Analytical methods
Determination of urinary tartaric acid concentration was carried
out according to a previously validated stable-isotope dilution
LC–ESI-MS/MS method(18). Briefly, urine samples (50ml) were
diluted 1:20 (v/v) with 0·5 % formic acid in water, and 10ml
of a 2H-labelled isotope standard solution in water (DL-(^)-
tartaric-2,3-d2 acid, 60mg/ml) were added. The sample
dilution was filtered using a 0·20mm filter and analysed by
LC–ESI-MS/MS. All samples were analysed in triplicate.
To normalise analyte concentrations in spot urine samples,
all results were corrected for urinary creatinine(20), and are
reported as mg tartaric acid/mg creatinine in the morning
urine. Urinary creatinine was determined by a modification
of Jaffe´’s alkaline picrate method(21).
LC–ESI-MS/MS analyses were performed on an Agilent 1100
Series HPLC system (Agilent Technologies) coupled to a triple
quadrupole mass spectrometer API 3000 (Applied Biosystems)
as described elsewhere(18). Chromatographic separation was
performed on a reversed-phase column Atlantis T3 C18
(100 £ 2·1 mm, 3mm) from Waters maintained at 258C.
Mobile phases A and B were, respectively, 0·5 % formic acid
in water and 0·5 % formic acid in acetonitrile. The following
linear gradient was used: held at 100 % A for 3·5 min,
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decreased to 10 % A over 2 min and held for 2 min, and then
returned to initial conditions for 1·5 min and re-equilibrated
for 6 min. The flow rate was set at 350ml/min and the injection
volume was 10ml. Post-column addition of acetonitrile
(250ml/min) was carried out to improve analyte ionisation
efficiency. Detection was accomplished in the multiple reac-
tion monitoring mode, and the following MS/MS transitions
were used for quantification and confirmation, respectively:
m/z 149/87 and m/z 149/73 for tartaric acid, and m/z 151/88
and m/z 151/74 for the 2H-labelled isotope.
Statistical analysis
Statistical calculations were made using the software package
GraphPad Prism version 5·0 (GraphPad Software). Unless
otherwise specified, data are presented as means and standard
deviations, and a 0·05 significance level was used. All data were
assessed for normality using the ‘omnibus K2’ D’Agostino–
Pearson and the Shapiro–Wilk normality tests. Since
concentration of urinary tartaric acid was not normally
distributed, the non-parametric Mann–Whitney U test and
Wilcoxon test were applied to determine statistical difference
between groups. Spearman’s rank correlation was used to
estimate the relationship between urinary excretion and wine
consumption. Receiver-operating characteristic (ROC) curve
analysis was performed on the concentration of urinary tartaric
acid to evaluate its sensitivity and specificity in the
discrimination between periods of abstention and wine
drinking. To determine the optimal cut-off value, ROC curves
were constructed using all possible cut-off points for each
assay. For sensitivity and specificity, 95 % CI were calculated
using the Clopper–Pearson exact binomial method.
Results
The estimated intake of tartaric acid for the three interventions
was 174 (SD 2), 347 (SD 3) and 521 (SD 5) mg for 100, 200 and
300 ml wine consumption, respectively.
The concentrationsofurinary tartaric acidbefore andafter each
intervention are shown in Fig. 2. After the 7 d washout periods,
the median urinary concentration was 1·06 (interquartile
range 0.56–1.78)mg/mg creatinine. After wine consumption,
a significant rise in its urinary concentration was observed. The
amount of tartaric acid increased by 27·0 (95% CI 22·9,
32·9)mg/mg (P , 0·001) after the intake of 100ml wine, by 52·5
(95% CI 44·5, 69·7)mg/mg (P , 0·001) after the intake of 200ml
wine and by 80·8 (95% CI 73·1, 107)mg/mg (P , 0·001) after
the intake of 300ml wine. The order of interventions did not
affect the results. Spearman’s correlation analysis revealed a
strong direct association between wine dose and urinary tartaric
acid (rs ¼ 0·9220; P , 0·001).
To assess the effectiveness of tartaric acid as a biomarker of
wine intake, a ROC curve was constructed, showing an AUC
of 100% (P , 0·001; Fig. 3). The optimal cut-off point was
8·84mg/mg creatinine (58·9 nmol/mg creatinine), which
allowed wine consumers to be differentiated from non-wine
consumers. This point had a sensitivity of 100% (95% CI
83·9, 100%) and a specificity of 100% (95% CI 83·9, 100%).
When trying to differentiate between the low dose (100ml)
and the intermediate dose (200ml), the resulting ROC curve
presented an AUC of 91·4% (95% CI 82·6, 100%; P , 0·001)
and an optimal cut-off value of 40·7mg/mg creatinine
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Fig. 1. Schematic representation of the study design. , Consumption of 100 ml wine at dinner; , consumption of 200 ml wine at dinner; , consumption of
300 ml wine at dinner; , basal urine sample; , post-intervention urine sample.
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Fig. 2. Box and whisker plot showing the median (central line), 25–75
percentiles (boxes) and the entire range (whiskers) for the urinary tartaric
acid concentration after the 7 d washout periods and after the intake of 100,
200 and 300 ml wine, respectively. **** Mean value was significantly different
from that of the washout period (P , 0·0001). †††† Mean value was
significantly different from that of the 200 ml intake (P , 0·0001).
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(271 nmol/mg creatinine), which resulted in a sensitivity of
85·7% (95% CI 63·7, 96·9%) and a specificity of 90·5%
(95% CI 69·6, 98·8%). Another ROC curve was obtained,
aiming to differentiate between the intake of 100 and 300ml
wine (Fig. 3). In this case, the AUC was 99·6% (95% CI 98·3,
100%; P , 0·001) and the optimal cut-off value was 48·7mg/mg
creatinine (324nmol/mg creatinine). This point had a
sensitivity of 100% (95% CI 83·9, 100%) and a specificity of
95·2% (95% CI 76·2, 99·9%).
Discussion
A major challenge for scientists investigating the health-
promoting effects of moderate wine consumption is to reliably
and accurately assess the consumption status in their clinical
and/or epidemiological studies.
In this regard, concentration of urinary TRM has been
previously proposed as a biomarker of wine intake. TRM
showed a significant dose–response effect (r 0·645;
P,0·001), and it was able to differentiate between wine
drinkers and non-wine drinkers with high sensitivity and
specificity (72 and 94 %, respectively) at a cut-off value of
90 nmol/g creatinine(8). Nevertheless, TRM has limitations as
a biomarker because resveratrol is not specific to grapes and
can also be found in peanuts, although at lower
concentrations(22,23); moreover, resveratrol content has
been shown to vary substantially among different types
of wine(9,22).
Further research is therefore needed to evaluate other wine
constituents or their metabolites in the human body as potential
biomarkers of wine consumption. The aim of the present study
was to examine whether tartaric acid, a main wine component,
might be a suitable biomarker of moderate wine consumption.
In contrast to resveratrol, with several important dietary
sources, the major source of tartaric acid in the diet is grapes,
and therefore also wine(13,14). Although it can be found in
other fruits such as bananas, its concentration levels can be con-
sidered negligible when compared with grapes or wine(14,24).
Only tamarind, a sour fruit whose consumption is mainly
restricted to tropical areas, presents comparable contents of
this acid(15).
Accordingly, after the washout periods, during which the
only dietary restriction was the consumption of wine or any
other grape-based products, a very low concentration of tartaric
acid was detected in the urine, probably due to the previous
intake of some food containing low levels of tartaric acid.
An effective nutritional biomarker should also be robust and
have a strong direct relationship with specific dietary
consumption(25,26). The strong correlation observed between
wine intake and urinary tartaric acid indicates that the
concentration of this acid in the urine reflects the amount of
wine consumed. Thus, its urinary concentration underwent a
27-fold increase after drinking only 100ml wine and almost
80-fold after consumption of 300ml wine. In a previous study
conducted in five male volunteers, the concentration of urinary
tartaric acid also significantly increased (P , 0·01) after
consumptionof 200ml redwine, reachingurinary levels between
35·1 and 91·8mg/mg creatinine(18). Similar results have been
reported by Lord et al.(27) in urine samples of two healthy men
after the consumption of two glasses of wine, which showed
an increase in tartaric acid concentrations from ,10mg/mg to
179 and 210mg/mg, respectively. In a further study with
twenty-three subjects, the same authors observed the dietary
impact of grape juice consumption on urinary tartrate, which
rose from 7·40 to 282mg/mg after the intake of 280ml grape
juice(16). More recently, Va´zquez-Fresno et al.(17) also reported
an increase in urinary tartaric acid concentrations in sixty-one
male volunteers with high cardiovascular risk factors after the
intake of 272ml red wine and dealcoholised red wine.
Since this acid comes directly from grapes, their
consumption as table grapes, raisins or processed into jams
and juices would also increase its urinary concentration in a
similar way to wine. However, most grapes are used for wine-
making (approximately 70 %), about 30 % are consumed fresh
and only a minor portion (,1 %) are consumed as raisins(28).
To the best of our knowledge, the influence of the food
matrix on the bioavailability of tartaric acid has not yet been
studied. Interestingly, with the exception of wine or grape-
based products, no restrictions were made regarding the
intake of food and beverages on the previous days or even
on the day of the intervention. Thus, the present results
were obtained under real feeding conditions, which suggested
that the absorption and excretion of tartaric acid is little
affected by the food matrix. This finding confirms that this
potential biomarker of wine intake would be selective
enough to be minimally affected by a general diet.
Another requirement is that the biomarker permits the
discrimination between different levels of consumption(29).
Under controlled trial conditions, a cut-off value of 8·84mg/mg
creatinine (58·9 nmol/mg creatinine) in the concentration of
urinary tartaric acid allowed consumers and non-consumers
of wine to be distinguished with maximal sensitivity and
Fig. 3. Receiver-operating characteristic (ROC) curves of urinary tartaric acid
to discriminate between wine and non-wine consumers, and between low
(100 ml) and moderate (300 ml) wine consumption in the clinical trial.
, Non-consumers v. 100 ml wine intake; , 100 v. 200 ml wine intake;
, 100 v. 300 ml wine intake.
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specificity (Fig. 3). A second ROC curve was constructed aiming
todifferentiate between the wine intakes of the low dose (100ml)
and the intermediate dose (200ml), obtaining a cut-off value of
40·7mg/mg creatinine (271nmol/mg creatinine), showing
enough sensitivity and specificity. Finally, a cut-off value of
48·7mg/mg creatinine (324nmol/mg creatinine) was established
to distinguish between low-dose (100ml) and moderate-dose
wine consumers (300ml), again showing maximal sensitivity
and specificity.95%.
It should be noted that the present data were obtained from a
randomised, controlled, cross-over study in which individuals
acted as their own controls, which are the optimal conditions
for investigating dietary biomarkers. Furthermore, these results
might not be generalisable to the women population as only
men were included in the present study. Therefore, further
research with free-living populations is necessary to determine
whether the excretion of tartaric acid can categorise individuals,
both men and women, according to their wine intake under
uncontrolled conditions.
In comparison with urinary resveratrol metabolites, urinary
tartaric acid has some potential advantages. In this context,
one of the major limitations of using resveratrol metabolites
is the highly varying concentration of resveratrol in wine,
usually within the range of 0·98–18·0 mg/l depending on the
grape variety(22). In addition, the concentration of resveratrol
in red wines is much higher than that in white wines, since
during the red winemaking, skins, which account for the
highest content of resveratrol in grapes(9,30), are macerated
with the juice, while in white winemaking, only the free-run
juice without skin contact is used.
Furthermore, it has been shown that colonic microbiota
may play a significant role in resveratrol metabolite
production, which needs further investigation due to high
inter-individual human microbiota variability(11).
In contrast, the concentration of tartaric acid in different wines
is far more constant, normally within the range of
1·5–4·0 g/l(12,13). Tartaric acid is mainly present in the grape
pulp, which is used for the winemaking of all kinds of wine, so
it would seem more suitable than TRM as a biomarker of wine
consumption, including wines with lower contents of resveratrol,
such as rose and whitewines. Another important advantage relies
on the much higher concentration of tartaric acid in wine com-
pared with resveratrol, usually more than 1000-fold. This fact,
along with the relatively high percentage of tartrate excreted
unchanged in the urine, 14–20% of ingested dose in human
subjects(31), would be responsible for the high concentrations
of tartaric acid in the urine after wine consumption. This enables
a faster sample preparation by simple urine dilution. From an
analytical point of view, it results in a reduction of sample
manipulation and cost, and at the same time increasing sustain-
ability, accuracy and precision in biomarker measurement.
On the basis of the present findings, urinary tartaric acid may
be considered as a sensitive, selective and robust biomarker of
moderate wine intake. The present study design did not
consider the potential of this acid as a long-term biomarker of
intake, especially if wine is episodically consumed. It is likely
that tartaric acid is a good short-term biomarker, and that a
single urine sample may not be sufficient to assess ‘usual’ intake.
Nevertheless, this biomarker could be used in studies in
which repeated samples are available and also in combination
with self-reported questionnaires to improve the accuracy of
intake assessment. The next step is to evaluate whether it
can improve the accuracy of intake assessment in epidemio-
logical studies, where the conditions of the participants are
less well controlled(32).
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